aminothiazolones as estrogen-related alpha receptor modulators. The present invention relates to compounds of formula (I), method for preparing these compounds, compositions, intermediates and derivatives thereof, and for treating a condition that includes, but is not limited to, ankylosing spondylitis, atherosclerosis, arthritis (as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those not responding to antiestrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury / loss, cartilage degeneration, and those related to cartilage formation), controdysplasia, chodrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, energy homeostasis disorders , gout, pseudogout, lipid disorders, metabolic syndrome lica, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, paget's disease, periodontal disease, rheumatic polymyalgia, reiter's syndrome, repetitive stress injury, hyperglycemia, high blood glucose level, and resistance to insulin.aminotiazolonas como moduladores do receptor alfa-relacionado ao estrôgenio. a presente invenção refere-se a compostos da fórmula (i), método para preparar estes compostos, composições, intermediários e derivados dos mesmos, e para tratar uma condição que inclui, mas não se limita a, espondilite anquilosante, arterosclerose, artrite (como artrite reumatoide, artrite infecciosa, artrite infantil, artrite psoriática, artrite reativa), doenças relacionadas aos ossos (incluindo aquelas relacionadas à formação óssea), câncer de mama (incluindo aqueles que não respondem a terapia antiestrogênica), distúrbios cardiovasculares, doença relacionada a cartilagem (como lesão/perda de cartilagem, degeneração de cartilagem
